Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including Population Health, Equity & Outcomes; Evidence-Based Oncology™; and The Center for Biosimilars®. She has been working on AJMC since 2014 and has been with AJMC’s parent company, MJH Life Sciences®, since 2011.
She has an MA in business and economic reporting from New York University. You can connect with Laura on LinkedIn or Twitter.
VA Won't Research Medical Marijuana for Chronic Pain or PTSD Among Veterans
An inquiry by 10 Democrats on the House Committee on Veterans’ Affairs into whether or not the Department of Veterans Affairs (VA) would research medical marijuana in veterans suffering from posttraumatic stress disorder (PTSD) and chronic pain was met with denial.
Express Scripts Is Built for the Future of Healthcare, Says CEO Wentworth
It’s true, pharmacy benefit managers (PBMs) are complicated, admitted Tim Wentworth, president and CEO of Express Scripts, during his presentation at the JP Morgan Healthcare Conference in San Francisco, California. However, the company is built to succeed in the future of healthcare, he said.
Gates Discusses the Hope of Using Immuno-Oncology for HIV Breakthroughs, and More
While public funding through the National Institutes of Health has created a foundation for healthcare research, the private sector can benefit from getting more involved, said Bill Gates, philanthropist and co-founder of Microsoft.
How Value Frameworks Define Durable Survival of New Immuno-Oncology Agents
New immuno-oncology agents are providing durable survival for some patients, but the cost of these treatments is very high, which is a cause for concern. In a new study in JAMA Oncology, researchers sought to assess how value frameworks defined the efficacy of new immuno-oncology agents.
Can Technology-Based Interventions Be Used to Improve Adherence Among Adolescents?
Low medication adherence is a problem in healthcare, in general. However, adolescents with chronic health conditions also have low adherence, but they are at a critical age when they can create routines and health behaviors that optimize disease management as they become adults.
Top 2017 AJMC® Articles Identify Ways to Reduce Costs and Improve Care Outcomes
With reimbursement increasingly tied to outcomes, health systems and practices are trying to find ways to reduce costs while delivering better care. Some of the most-read articles in The American Journal of Managed Care® (AJMC®) in 2017 included an analysis of the benefits of treating everyone with hepatitis C with new, expensive treatments, a program to reduce readmissions, and a look at the impact of value-based contracting in Medicare Advantage.
Diagnosing Congenital Neutropenia
Physicians caring for patients with severe congenital neutropenia should be ready to detect issues with multiple systems in the body, explained Seth Corey, MD, of the Virginia Commonwealth University and the Massey Cancer Center & Children's Hospital of Richmond, during a session at the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta, Georgia.
Developing State-Level Programs for Care of Complex Populations
Using lessons learned from the past 4 years of working with 10 states and Puerto Rico, the National Governors Association Center for Best Practices Health Division has released a road map to guide states in establishing state-level solutions to care for complex populations.
New SGLT2 Competitor Steglatro Approved for Type 2 Diabetes
A new sodium-glucose co-transporter 2 medication to treat type 2 diabetes is joining the field: the FDA approved ertugliflozin (Steglatro) from Merck and Pfizer as a single therapy and in combination with Merck’s sitagliptin (Januvia), a DPP-4 inhibitor, or with metformin.
AJMC®tv Interviews, December 2017
AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers—from the clinician, to the health plan leader, to the regulator. When every minute in your day matters, AJMC®TV interviews keep you informed. Access the video clips at ajmc.com/interviews.
New Drug Approvals in Leukemia and Lymphoma Presented at ASH 2017
The FDA was busy in 2017, with a number of notable approvals, including the first chimeric antigen receptor T-cell treatment. In a session at the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta, Georgia, employees from the FDA presented data on 5 new drug approvals in leukemia and lymphoma in 2017.
Diagnosing Non-Chemotherapy Drug-Induced Neutropenia
In a session at the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta, Georgia, Brian Curtis, PhD, of the BloodCenter of Wisconsin Blood Research Institute, highlighted drugs other than chemotherapy that may cause neutropenia in patients.
Report Highlights Increase in Premature Deaths in the United States
An analysis of behaviors, community environment, policy, clinical care, and outcomes data has found a disturbing trend in mortality in the United States, with premature deaths, drug deaths, and cardiovascular deaths all increasing.
Five Years of Reducing Overuse of Medical Services With Choosing Wisely
Overuse of medical services has been a costly issue in US healthcare for decades. Now in its fifth year, the Choosing Wisely initiative from ABIM Foundation seeks to increase conversations between physicians and patients to help them make wise decisions about appropriate care and reduce the use of low-value services.
How Physicians Handle Differing Guidelines on Breast Cancer Screening Recommendations
WIth different societies and organizations releasing contrary guidelines around breast cancer screening, experience with past patients or friends and family members could influence physicians' decisions around when to start screening mammography.
Identifying Differences of Symptoms of Patients With Severe COPD in 3 Countries
A study of patients with severe chronic obstructive pulmonary disease (COPD) in Poland, The Republic of Korea, and the United States identified substantial differences in respiratory symptoms and other respiratory illnesses.
CVS to Purchase Aetna With Idea of Remaking Consumer Healthcare Experience
CVS Health has proposed purchasing health insurer Aetna in a $69 billion deal that could disrupt the pharmacy benefit management business and "remake the consumer healthcare experience," according to CVS Health's president and CEO.
Verma's Vision for CMS: Going Digital and Less Regulatory Burden
CMS is focusing on patient empowerment and unburdening physicians, said CMS Administrator Seema Verma during her keynote speech at the Office of the National Coordinator for Health Information Technology’s Annual Meeting.